Search

Displaying results 6641 - 6650 of 10000 in total
  1. Drug

    Rineterkib

    go.drugbank.com/drugs/DB17560
    Investigational

    Rineterkib is an inhibitor of extracellular signal-regulated kinase (ERK) being investigated in NCT04097821 (A Randomized, Open-label, Phase I/II Open Platform Study Evaluating Safety and Efficacy of Novel

  2. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications.

  3. Drug

    ARI-0001

    go.drugbank.com/drugs/DB30635
    Investigational

    ARI-0001 is under investigation in clinical trial NCT05641428 (Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL).

  4. Drug

    Neutramycin

    go.drugbank.com/drugs/DB20809
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Neutramycin is a antibiotic, produced by Streptomyces strain. Neutramycin has a monoisotopic molecular weight of 686.35 Da.

  5. Drug

    Amniotic membrane

    go.drugbank.com/drugs/DB33970
    Experimental

    Amniotic membrane is under investigation in clinical trial NCT07824596 (The Role of Amniotic Membrane in Promoting Rapid Recovery of Buccal Mucosal Defect After Harvesting Oral Mucosa for Urethral Reconstruction

  6. Drug

    Alpha-galactosylceramide

    go.drugbank.com/drugs/DB12232
    Investigational

    KRN7000 has been used in trials studying the treatment of Lung Cancer, Chronic Hepatitis C, Hepatitis B, Chronic, Unspecified Adult Solid Tumor, Protocol Specific, and Prevention of GvHD in Patients With

    Synonyms: 1-O-(α-D-galactopyranosyl)-N-hexacosanoylphytosphingosine
  7. Drug

    Ubenimex

    go.drugbank.com/drugs/DB03424
    Investigational

    It is an inhibitor of aminopeptidase B, leukotriene A4 hydrolase, aminopeptidase N. It is being studied for use in the treatment of acute myelocytic leukemia.

  8. Drug

    Anthramycin

    go.drugbank.com/drugs/DB19555
    Experimental

    The usage of the INN stem '-mycin' in the name indicates that Anthramycin is a antibiotic, produced by Streptomyces strain. Anthramycin has a monoisotopic molecular weight of 315.12 Da.

  9. Drug

    Nitraquazone

    go.drugbank.com/drugs/DB19659
    Experimental

    The usage of the INN stem '-azone' in the name indicates that Nitraquazone is a anti-inflammatory analgesic, phenylbutazone derivative. Nitraquazone has a monoisotopic molecular weight of 311.09 Da.

  10. Drug

    Isoxepac

    go.drugbank.com/drugs/DB19733
    Experimental

    The usage of the INN stem '-ac' in the name indicates that Isoxepac is a anti-inflammatory agent, ibufenac derivative. Isoxepac has a monoisotopic molecular weight of 268.07 Da.